LivaNova LIVN
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
LivaNova (LIVN) Core Market Data and Business Metrics
Latest Closing Price
$39.5Price-Earnings Ratio
34.05Total Outstanding Shares
54.35 Million SharesDividend
No dividendSIC Description
Electromedical & Electrotherapeutic ApparatusPrimary Exchange
NASDAQHeadquarters
20 Eastbourne Terrace, London, X0, W2 6LG
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 847,501 Shares | 1.83 | 3/14/2025 | 1,554,231 Shares |
| 1,027,010 Shares | 1.54 | 2/28/2025 | 1,582,372 Shares |
| 361,270 Shares | 5.36 | 2/14/2025 | 1,936,152 Shares |
| 493,146 Shares | 4.07 | 1/31/2025 | 2,008,473 Shares |
| 461,110 Shares | 4.96 | 1/15/2025 | 2,288,127 Shares |
| 495,190 Shares | 4.46 | 12/31/2024 | 2,209,039 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $18.55 Million |
| Net Cash Flow From Operating Activities, Continuing | $183.04 Million |
| Net Cash Flow From Investing Activities, Continuing | $-48.16 Million |
| Net Cash Flow | $145.68 Million |
| Net Cash Flow From Investing Activities | $-48.16 Million |
| Exchange Gains/Losses | $-7.75 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Costs And Expenses | $1.17 Billion |
| Net Income/Loss Attributable To Parent | $63.23 Million |
| Income/Loss From Equity Method Investments | $-18,000 |
| Income/Loss From Continuing Operations After Tax | $63.25 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $63.23 Million |
| Selling, General, and Administrative Expenses | $526.26 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $10.95 Million |
| Comprehensive Income/Loss Attributable To Parent | $10.95 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-52.29 Million |
| Other Comprehensive Income/Loss | $10.95 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Noncurrent Assets | $1.38 Billion |
| Other Current Liabilities | $322.40 Million |
| Long-term Debt | $627 Million |
| Equity | $1.32 Billion |
| Accounts Payable | $69.73 Million |
| Current Assets | $1.13 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||